Last reviewed · How we verify
Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up
This study is conducted within the frame of the Post-Market Surveillance (PMS) activities, as described in the Post Market Clinical Follow-up (PMCF) plan of Vectorio®. This study aims at collecting clinical data, to confirm the General Safety and Performance Requirements of Vectorio® which is a Lipiodol Resistant Mixing \& Injection System for cTACE.
Details
| Lead sponsor | Guerbet |
|---|---|
| Status | UNKNOWN |
| Enrolment | 50 |
| Start date | Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Mar 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Oncology
Countries
Switzerland, Austria, France